| 000 | 01519 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513213239.0 | ||
| 264 | 0 | _c20000724 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaniel, E E | |
| 245 | 0 | 0 |
_aNitric oxide from enteric nerves acts by a different mechanism from myogenic nitric oxide in canine lower esophageal sphincter. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 2000 |
||
| 300 |
_a270-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid _xpharmacology |
| 650 | 0 | 4 |
_a4-Aminopyridine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aChloride Channels _xphysiology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEsophagogastric Junction _xphysiology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntestines _xinnervation |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aNitroarginine _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Channels _xphysiology |
| 650 | 0 | 4 |
_aTetraethylammonium Compounds _xpharmacology |
| 650 | 0 | 4 |
_aomega-Conotoxin GVIA _xpharmacology |
| 700 | 1 | _aJury, J | |
| 700 | 1 | _aSalapatek, A M | |
| 700 | 1 | _aBowes, T | |
| 700 | 1 | _aLam, A | |
| 700 | 1 | _aThomas, S | |
| 700 | 1 | _aRamnarain, M | |
| 700 | 1 | _aNguyen, V | |
| 700 | 1 | _aMistry, V | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 294 _gno. 1 _gp. 270-9 |
|
| 999 |
_c10822109 _d10822109 |
||